📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
TRIDENT TEXOFAB LIMITEDTTFLOther Textile Products
Open
42.8
High
43.22
Low
41.79
Close
43.22
Volume
11431
Exchange
bse
Time
21-May-2026

Outlook

Score:  

4.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Trident Texofab is  
Short Body
Estimated Stoploss of Trident Texofab is ₹  
41.79
Trident Texofab has a  
Bullishℹ
 pattern. 
Formation of  
Short Body
 candle pattern indicates the trend direction of Trident Texofab is  
Unpredictableℹ
. 

Trend

Trident Texofab is in  
Sideways trendℹ
. 
Price of Trident Texofab is  
Downℹ
 by  

15.06

%. 
Target
Buy @ 

26.07

Sell @ 

86.97

Current @ 

43.22

Volume

The trade volumes of Trident Texofab have become  
Deficientℹ
The volume trend for Trident Texofab is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Trident Texofab is  

Down

 by  

83.35

% 

Valuation

The current market price of Trident Texofab is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 100cr and total assets worth ₹ 100cr, the balance sheet of Trident Texofab is:  
Balancedℹ
. 
Cashflow
Trident Texofab has  
Sufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

40.63% in operatingℹ
3.13% in investingℹ
56.25% in financingℹ
0% in otherℹ
Trident Texofab has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
50% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
Income
The income of Trident Texofab is  

₹ 31cr

 and  

Profit

 is :  

₹ 1cr

(*Sep 2025)

Trident Texofab Profit is up by:  

100

% and Income is Down by:  

26.32

% 

(*Sep 2025)

The income of Trident Texofab is  

₹ 28cr

 and  

Loss

 is :  

₹ 1cr

(*Jun 2025)

Trident Texofab Losses increased by:  

0

% and Income is Up by:  

22.58

% 

(*Jun 2025)

The income of Trident Texofab is  

₹ 38cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Trident Texofab Losses increased by:  

100

% and Income is Up by:  

6.9

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.